Next-generation sequencing (NGS) is a technology for determining the sequence of DNA or RNA to study genetic variation associated with diseases or other biological phenomena. LabQuest Diagnostic Limited uses NGS technology that offers ultra-high throughput, scalability, and speed for human genetic disease findings such as chromosomal aneuploidy screening, cancer diagnosis, inherited disease diagnosis, and so on. Through NGS we are providing the following test services, including NIPT, BRCA1 & BRCA2, lung cancer, colon cancer, and whole exome sequencing.
Ion GeneStudio™ S5 Platform
(Thermofisher Scientific, USA)